Zyvex Corporation Jobs in Virginia

Company:
Zyvex Corporation
Current Opportunities (0)
Company Website
Location(s):
1321 North Plano Road
Richardson,  TX
75081
Map Location
Phone:
(972) 235-7881
Fax:
(972) 235-7882
Industry:
Manufacturing / R&D (non-computer)
Size:
50-99

Company Overview

Founded by James R. Von Ehr II in 1997, Zyvex is the first molecular nanotechnology company. Von Ehr’s business acumen, determination, and financial support have enabled Zyvex to become the most publicized private nanotechnology business in the world and the most highly regarded company in the field of molecular assemblers. Von Ehr himself is widely respected as one of the world’s top nanotechnology industry leaders.

Zyvex’s mission is to become the leading worldwide supplier of tools, products, and services that enable adaptable, affordable, and molecularly precise manufacturing.

We have spent the last few years building a world-class executive and technical team. Our state-of-the-art laboratories support our scientists and engineers with equipment not available to typical early-stage companies. We focus on some of the most fundamental core issues facing nanotechnology development and commercialization as we evolve from a technology-oriented to market-driven enterprise.

We are a unique early-stage company, as we are financially stable, possess a solid infrastructure and processes for rapid growth, and have world-class scientists and engineers. Our staff is focused on both short and long-term nanotechnology applications with high-growth potential to guarantee our success as a driving force in our field.

In 2001, NIST awarded Zyvex a $25 Million research program. Under this Advanced Technology Program, Zyvex and its collaborators will accelerate the production and commercialization of low cost assemblers for micro- and nanoscale components and subsystems.

Our potential customer base includes all manufacturing and assembly industries. The company is targeting specific applications in the Aerospace/Defense, Electronics/Telecommunications, and Medical/HealthCare industries. Our short- to intermediate-term goal is to exploit the major improvements—often 10–1,000 times better than existing technology—offered by today’s early-stage nanotechnology developments.

Zyvex is one of the few firms that generate revenue and is regarded as a nanotechnology business—as evidenced by continual invitations to speak at the country’s top business schools.